Lukas Biomedical Inc. (TPEX:6814)

Taiwan · Delayed Price · Currency is TWD

18.60

+0.10 (0.54%)

Oct 30, 2026, 11:24 AM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Medical Management Operations	47.26M	54.71M	57.43M	69.63M	84.63M
e-Commerce Department	113.70M	120.71M	152.29M	106.21M	69.93M
Pharmaceutical Market Development Department	18.54M	14.42M	22.09M	8.95M	-
Cell Products Division	-	-	28.00K	-	3.06M
ALL Other Departments	-	-	-	-	43.00K
Total	179.49M	189.83M	231.83M	184.79M	157.66M

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Taiwan	177.80M	187.66M	203.98M	184.79M	157.62M
United State	109.00K	26.00K	50.00K	-	-
Thailand	111.00K	1.95M	-	-	-
Vietnam	1.48M	-	-	-	-
Hong Kong	-	200.00K	-	-	-
Japan	-	-	27.80M	-	-
Total	179.49M	189.83M	231.83M	184.79M	157.62M